Osteonecrosis of the jaw in oncology patients treated with bisphosphonates: prospective experience of a dental oncology referral center

References

1. • Migliorati C.A.
   • Schubert M.M.
   • Peterson D.E.
   Bisphosphonate osteonecrosis (BON): unanswered questions and research possibilities.
   Rev Recent Clin Trials. 2009; 4: 99-109
   View in Article

   • Google Scholar
2. • Ruggiero S.
   • Dodson T.B.
   • Assael L.A.
   • Landesberg R.
   • Marx R.E.
   • Mehrotra B.
   • et al.
   American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws—2009 update.
   J Oral Maxillofac Surg. 2009; 67: 2-12
   View in Article

   • Google Scholar
3. • Migliorati C.A.
   • Woo S.B.
   • Hewson I.
   • Barasch A.
   • Elting L.
   • Spijkervet F.
   • et al.
   A systematic review of bisphosphonate osteonecrosis (BON) in cancer.
   Support Care Cancer. 2010; 18: 1099-1106
   View in Article

   • Google Scholar
4. • Wang J.
   • Goodger N.M.
   • Pogrel M.A.
   Osteonecrosis of the jaws associated with cancer chemotherapy.
   J Oral Maxillofac Surg. 2003; 61: 1104-1107
   View in Article

   • Google Scholar
5. • Ruggiero S.
   • Mebrotra B.
   • Rosenberg T.
   • Engroff S.
   Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases.
   J Oral Maxillofac Surg. 2004; 62: 527-534
   View in Article

   • Google Scholar
6. • Bagan J.V.
   • Murillo J.
   • Jimenez Y.
   • Poveda R.
   • Milian M.A.
   • Sanchis J.M.
   • et al.
   Avascular jaw osteonecrosis in association with cancer chemotherapy: a series of 10 cases.
   J Oral Pathol Med. 2005; 34: 120-123
   View in Article

   • Google Scholar
7. • Migliorati C.A.
   • Schubert M.M.
   • Peterson D.E.
   • Seneda L.M.
   Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone.
   Cancer. 2005; 104: 83-93
   View in Article

   • Google Scholar
8. • Migliorati C.A.
   • Armonis B.N.
   • Nicolatou-Galitis O.
   Oral osteonecrosis associated with the use of ibandronate: report of a case and clinical implications.
   Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008; 106: e18-e21
   View in Article

   • Google Scholar
9. • Bamias A.
   • Kastritis E.
   • Bamia C.
   • Moulopoulos L.
   • Melakopoulos I.
   • Bozas G.
   • et al.
   Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors.
   J Clin Oncol. 2005; 23: 8580-8587
   View in Article

   • Google Scholar
10. • Durie B.G.M.
    • Katz M.
    • Crowley J.
    Osteonecrosis of the jaw and bisphosphonates.
    N Engl J Med. 2005; 353: 99-102
    View in Article

    • Google Scholar
11. • Mavrokokki T.
    • Stein B.
    • Goss A.
    Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.
    J Oral Maxillofac Surg. 2007; 65: 415-423
    View in Article

    • Google Scholar
12. • Walter C.
    • Al-Nawas B.
    • Grotz K.A.
    • Thomas C.
    • Thuroff J.W.
    • Zinser V.
    • et al.
    Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate.
    Eur Urol. 2008; 54: 1066-1072
    View in Article

    • Google Scholar
13. • Boonyapakorn T.
    • Schirmer I.
    • Reichart P.A.
    • Sturm I.
    • Massenkeil G.
    Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies.
    Oral Oncol. 2008; 44: 857-869
    View in Article

    • Google Scholar
14. • Kyrgidis A.
    • Vahtsevanos K.
    • Koloutsos G.
    • Andreadis C.
    • Boukovinas I.
    • Teleiouidis Z.
    • et al.
    Bisphosphonate-related osteonecrosis of the jaws: a case-control study of risk factors in breast cancer patients.
    J Clin Oncol. 2008; 26: 4634-4638
    View in Article

    • Google Scholar
15. • Vahtsevanos K.
    • Kyrgidis A.
    • Verrou E.
    • Katodritou E.
    • Triaridis S.
    • Andreadis C.
    • et al.
    Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw.
    J Clin Oncol. 2009; 27: 5356-5362
    View in Article

    • Google Scholar
16. • Van den Wyngaert T.
    • Claeys T.
    • Huizing M.T.
    • Vermorken J.B.
    • Fossion E.
    Initial experience with conservative treatment in cancer patients with osteonecrosis of the jaw (ONJ) and predictors of outcome.
    Ann Oncol. 2009; 20: 331-336
    View in Article

    • Google Scholar
17. • Walter C.
    • Al-Navas B.
    • Frickhofen N.
    • Gamm H.
    • Beck J.
    • Reinsch L.
    • et al.
    Prevalence of bisphosphonate associated osteonecrosis of the jaws in multiple myeloma patients.
    Head Face Med. 2010; 6: 11
    View in Article

    • Google Scholar
18. • Wang E.P.
    • Kaban L.B.
    • Strewler G.L.
    • Raje N.
    • Troulis M.J.
    Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy.
    J Oral Maxillofac Surg. 2007; 65: 1328-1331
    View in Article

    • Google Scholar
19. • Jadu F.
    • Lee L.
    • Pharaoh M.
    • Reece D.
    • Wang L.
    A retrospective study assessing the incidence, risk factors and comorbidities of pamidronate-related necrosis of the jaws in multiple myeloma patients.
    Ann Oncol. 2007; 18: 2015-2019
    View in Article

    • Google Scholar
20. • Hoff A.O.
    • Toth B.B.
    • Altundag K.
    • Johnson M.M.
    • Warneke C.L.
    • Hu M.
    • et al.
    Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates.
    J Bone Miner Res. 2008; 23: 826-836
    View in Article

    • Google Scholar
21. • Walter C.
    • Al-Nawas B.
    • du Bois A.
    • Buch L.
    • Harter P.
    • Grotz K.A.
    Incidence of bisphosphonate-associated osteonecrosis of the jaws in breast cancer patients.
    Cancer. 2009; 115: 1631-1637
    View in Article

    • Google Scholar
22. • Zervas K.
    • Verrou E.
    • Teleioudis Z.
    • Vahtsevanos K.
    • Banti A.
    • Mihou D.
    • et al.
    Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single-centre experience in 303 patients.
    Br J Hematol. 2006; 134: 620-623
    View in Article

    • Google Scholar
23. • Wessel J.H.
    • Dodson T.B.
    • Zavras A.I.
    Zoledronate and other risk factors associated with osteonecrosis of the jaw in cancer patients: a case-control study.
    J Oral Maxillofac Surg. 2008; 66: 625-631
    View in Article

    • Google Scholar
24. • Estilo C.L.
    • Van Poznak C.H.
    • Williams T.
    • Bohle G.C.
    • Lwin P.T.
    • Zhou Q.
    • et al.
    Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy.
    Oncologist. 2008; 13: 911-920
    View in Article

    • Google Scholar
25. • La Verde N.
    • Bareggi C.
    • Garassino M.
    • Borgonovo K.
    • Sburlati P.
    • Pedretti D.
    • et al.
    Osteonecrosis of the jaw (ONJ) in cancer patients treated with bisphosphonates: how the knowledge of a phenomenon can change its evolution.
    Support Care Cancer. 2008; 16: 1311-1315
    View in Article

    • Google Scholar
26. • Woo S.-B.
    • Hellstein J.W.
    • Kalmar J.R.
    Systematic review: bisphosphonates and osteonecrosis of the jaws.
    Ann Intern Med. 2006; 144: 753-761
    View in Article

    • Google Scholar
27. • Ruggiero S.L.
    • Gralow J.
    • Marx R.E.
    • Hoff A.O.
    • Schubert M.M.
    • Huryn J.M.
    • et al.
    Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer.
    J Oncol Pract. 2006; 2: 7-14
    View in Article

    • Google Scholar
28. • Ruggiero S.L.
    • Fantasia J.
    • Carlson E.
    Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006; 102: 433-441
    View in Article

    • Google Scholar
29. • Dickinson M.
    • Prince H.M.
    • Kirsa S.
    • Zannettino A.
    • Gibbs S.D.J.
    • Mileshkin L.
    • et al.
    Osteonecrosis of the jaw complicating bisphosphonate treatment for bone disease in multiple myeloma: an overview with recommendations for prevention and treatment.
    Intern Med J. 2009; 39: 304-316
    View in Article

    • Google Scholar
30. • Migliorati C.
    • Casiglia J.
    • Epstein J.
    • Jacobsen P.
    • Siegel M.
    • Woo S.
    Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper.
    J Am Dent Assoc. 2005; 136: 1658-1668
    View in Article

    • Google Scholar
31. • Dimopoulos M.A.
    • Kasritis E.
    • Bamia C.
    • Melakopoulos I.
    • Gika D.
    • Roussou M.
    • et al.
    Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zolendronic acid.
    Ann Oncol. 2009; 20: 117-120
    View in Article

    • Google Scholar
32. • Ripamonti C.I.
    • Maniezzo M.
    • Campa T.
    • Fagnoni E.
    • Brunelli C.
    • Saibene G.
    • et al.
    Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumor patients with bone metastases treated with bisphosphonates.
    Ann Oncol. 2009; 20: 137-145
    View in Article

    • Google Scholar
33. • Badros A.
    • Terpos E.
    • Katodritou E.
    • Goloubeva O.
    • Kastritis E.
    • Verrou E.
    • et al.
    Natural history of osteonecrosis of the jaw in patients with multiple myeloma.
    J Clin Oncol. 2008; 26: 5904-5909
    View in Article

    • Google Scholar
34. • Magopoulos C.
    • Karakinaris G.
    • Teleioudis Z.
    • Vahtsevanos K.
    • Dimitrakopoulos I.
    • Antoniadis K.
    • et al.
    Osteonecrosis of the jaws due to bisphosphonate use.
    Am J Otolaryngol. 2007; 28: 158-163
    View in Article

    • Google Scholar